|
AMO VERISYSE Phakic
Lens Implant:
Harvard Eye Associates — 30 Years
of Lens Implant Experience!
The First Implantable Contact Lens!
|
TIME magazine
says: "One
of The Most Amazing Inventions of 2004"
Every day, one patient at a time, all of us at Harvard Eye Associates
strive to provide the latest proven vision
solutions for you and your loved ones. If you are interested in seeing
your best, please contact Harvard Eye Associates
to evaluate the appropriateness of the Verisyse
lens implant for you. Together, we will discuss
the benefits, risks and costs.
|
What Is the Verisyse Phakic Lens Implant?
The
Verisyse phakic intraocular lens (IOL), manufactured by AMO (Advanced Medical
Optics), is a tiny plastic lens that is surgically implanted inside of your
eye between the cornea and the iris, and is used
for the correction of moderate to severe nearsightedness (myopia). The Verisyse
acts as a "helper" lens to reduce refractive error
and is an alternative to conventional or wavefront
Lasik, All-Laser Lasik, PRK, LASEK, and Epi-Lasik
for patients with very high myopic (nearsighted-shortsighted)
vision.
This type
of lens is called "phakic" because
your eye retains its natural lens, whereas "pseudophakic" refers
to the removal of the natural lens, such as occurs during cataract surgery.
Allowing your natural lens to stay in place retains its ability to "accommodate"
or see objects
that are both near and far without glasses. Although
the Verisyse phakic IOL is intended to be permanent, the procedure is
potentially reversible.
The Verisyse lens implant was the first phakic implantable
contact lens approved by the FDA. Available in Europe
for more than a dozen years, over 150,000 Verisyse lenses have been successfully
implanted worldwide. An acrylic implantable contact lens, the
Verisyse lens
is made of polymethylmethacrylate (PMMA), the same material in many
intraocular lens implants used in the eyes for over 50 years and
proven biocompatible.
The Verisyse lens can improve your distance vision, with
the goal of eliminating glasses and contact lenses. This revolutionary implant
procedure gives the eye another focusing lens
to provide the same quality and definition as that of a youthful healthy
eye. By placing the Verisyse phakic IOL micro lens behind your cornea and
on top of your iris, your Harvard Eye eye surgeon alters
the configuration of your eye for the correction of moderate to severe nearsightedness.
Inserted through a tiny incision and implanted in front of the eye's natural
lens, the Verisyse lens works by bending light rays so that they focus on
the retina.
Follow this link to read about: HOW THE
EYE FUNCTIONS
For High Degrees of Nearsightedness
Depending upon the architecture
of your eye, the size of the pupil, and the thickness of the cornea, LASIK
and PRK can be used to correct up to approximately -10 diopters of nearsightedness.
However, for patients with higher degrees of nearsightedness, LASIK and PRK
are often are not suitable choices.
Today, for people with -10 to -20 diopters of myopia
(nearsightedness), the Harvard Eye team offers
this promising new procedure. The Verisyse lens implant has been tested and
successfully used on thousands of patients in Europe since 1990. In the United
States, clinical studies of the Verisyse lens implant procedure began in 1997
and ended in 2003. During that time, over 1000 lenses were implanted in over
500 patients. In this study, over 84% of subjects achieved 20/40 vision
or better without the use of glasses or contact lenses (20/40 vision allows
people to legally drive without glasses). The Verisyse Phakic IOL was approved
by the Food and Drug Administration in September of 2004 and recognized as
one of the most impressive advancements in vision science. The Verisyse lens
implant is the first implantable lens especially designed to help people
who are too nearsighted for LASIK and PRK.
Are You a Good Candidate? next page —>
|
